Biomaterial suture Vicryl Plus reduces wound-related complications

Figures & data

Figure 1 Vicryl Plus suture used in craniotomy surgery.

Figure 2 Grading of selected CNS tumors according to the 2016 CNS WHO.

Note: Reprinted by permission from Springer Nature: Springer, Acta Neuropathol. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Louis DN, Perry A, Reifenberger G, et al. 2016;131(6):803–820.⁴
Abbreviations: CNS, central nervous system; MPNST, malignant peripheral nerve sheath tumor; WHO, World Health Organization.

Table 1 Baseline patient characteristics of the two groups

Characteristic	Vicryl Plus	Traditional	X^2/t	P-value
	n=129	n=116
Sex (male)	71 (55.0)	69 (59.5)	0.493	0.483
Age (<50 years)	83 (63.3)	80 (69.0)	0.587	0.444
Epilepsy	42 (32.6)	37 (31.9)	0.012	0.912
Extent of resection
Subtotal	55 (42.6)	36 (31.0)	3.521	0.061
Total	74 (57.4)	80 (69.0)
KPS on admission	75.9±11.4	73.3±11.6	1.774	0.077
Male	76.2±12.1	74.2±11.3	−1.007	0.316
Female	77.2±11.4	71.9±12.1	2.321	0.022
WHO grade
I	3 (2.3)	1 (0.9)	7.111*	0.068
II	58 (45.0)	46 (39.7)
III	41 (31.8)	28 (24.1)
IV	27 (20.9)	41 (35.3)

Notes: Data presented as mean±SD or number (%).

* Corrected chi-square test.

Abbreviations: KPS, Karnofsky Performance Status; WHO, World Health Organization.

Table 2 Wound-related complications and medical expenses of two groups

	Cases	Wound-related complications	Expenses (RMB)
Vicryl Plus	129	11 (8.5)	93,410.3±34,329.6
Traditional	116	20 (17.2)	86,279.9±38,261.3
X^2		4.995	1.538
P-value		0.025	0.125

Note: Data presented as number (%) or mean±SD.

Abbreviation: RMB, renminbi.

LouisDNPerryAReifenbergerGThe 2016 World Health Organization classification of tumors of the central nervous system: a summaryActa Neuropathol2016131680382027157931

 PubMed Web of Science ®Google Scholar